Miriam Kidron
16Patents
5h-index
5Co-inventors
59Inventor score
Filing activity: May 9, 1984 → Jan 31, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US4579730A | Pharmaceutical compositions containing insulin | Human Necessities | 115 | Expired |
| US9186412B2 | Methods and compositions for oral administration of insulin | Human Necessities | 43 | Active |
| US9259456B2 | Methods and compositions for oral administration of proteins | Human Necessities | 16 | Active |
| US10010503B2 | Methods and compositions for oral administration | Human Necessities | 9 | Active |
| US10420721B2 | Methods and compositions for oral administration | Human Necessities | 5 | Active |
| US10398762B2 | Methods and compositions for treating diabetes | Human Necessities | 4 | Active |
| US10058593B2 | Methods and compositions for oral administration of proteins | Human Necessities | 4 | Active |
| US10350162B2 | Methods and compositions for oral administration of exenatide | Human Necessities | 4 | Active |
| US10342764B2 | Protease inhibitor-containing compositions, compositions comprising same, and methods for producing and using same | Human Necessities | 4 | Active |
| US10881714B2 | Methods and compositions for oral administration of proteins | Human Necessities | 1 | Active |
| US10967051B2 | Methods and compositions for treating NAFLD, hepatic steatosis, and sequelae thereof | Human Necessities | 0 | Active |
| US10933022B2 | Protease inhibitor-containing compositions, compositions comprising same, and methods for producing and using same | Human Necessities | 0 | Active |
| US11246827B2 | Methods and compositions for oral administration | Human Necessities | 0 | Active |
| US11395848B2 | Methods and compositions for treating diabetes | Human Necessities | 0 | Active |
| US12311051B2 | Methods and compositions for oral administration | Human Necessities | 0 | Active |
| US11660327B2 | Methods and compositions for oral administration of proteins | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.